First-in-class Claudin 18.2 targeting radiopeptide, 64Cu-PD-29875 and 177Lu-PD-29875, exhibit promising theranostic potential in a pancreatic cancer xenograft …
用户sToGMn7iJdc8
10天前
45
10
已关闭
DOI:
文献链接:
其他信息:

